Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Noninfectious causes of diffuse pulmonary infiltrations in chronic renal failure: metastatic pulmonary calsification.

Kaya SB, Deger S, Hacievliyagil SS, Aytemur ZA.

Adv Respir Med. 2019;87(1):46-49. doi: 10.5603/ARM.a2019.0007. Epub 2019 Mar 4.

2.

Acute amiodarone toxicity causing respiratory failure.

Kaya SB, Deger S, Hacievliyagil SS, Aytemur ZA.

Rev Assoc Med Bras (1992). 2017 Mar;63(3):210-212. doi: 10.1590/1806-9282.63.03.210.

3.

Relationship between vitamin D and lung function, physical performance and balance on patients with stage I-III chronic obstructive pulmonary disease.

Yumrutepe T, Aytemur ZA, Baysal O, Taskapan H, Taskapan CM, Hacievliyagil SS.

Rev Assoc Med Bras (1992). 2015 Mar-Apr;61(2):132-8. doi: 10.1590/1806-9282.61.02.132.

4.
5.

Prognostic role of the simplified pulmonary embolism severity index and shock index in pulmonary embolism.

Kilic T, Ermis H, Gülbas G, Kaya O, Aytemur ZA, Inceoglu F, Hacievliyagil SS.

Pol Arch Med Wewn. 2014;124(12):678-87. Epub 2014 Oct 10.

6.

Airway inflammatory markers in chronic obstructive pulmonary disease patients and healthy smokers.

Hacievliyagil SS, Mutlu LC, Temel İ.

Niger J Clin Pract. 2013 Jan-Mar;16(1):76-81. doi: 10.4103/1119-3077.106771.

7.

Effects of iloprost on bleomycin-induced pulmonary fibrosis in rats compared with methyl-prednisolone.

Aytemur ZA, Hacievliyagil SS, Iraz M, Samdanci E, Ozerol E, Kuku I, Nurkabulov Z, Yildiz K.

Rev Port Pneumol. 2012 Nov-Dec;18(6):272-7. doi: 10.1016/j.rppneu.2012.04.010. Epub 2012 Jul 6.

8.

Alterations in the pulmonary function tests of inflammatory bowel diseases.

Ateş F, Karincaoğlu M, Hacievlıyagıl SS, Yalniz M, Seçkın Y.

Turk J Gastroenterol. 2011 Jun;22(3):293-9.

9.

Venous thromboemboli and exacerbations of COPD.

Gunen H, Gulbas G, In E, Yetkin O, Hacievliyagil SS.

Eur Respir J. 2010 Jun;35(6):1243-8. doi: 10.1183/09031936.00120909. Epub 2009 Nov 19. Erratum in: Eur Respir J. 2010 Nov;36(5):1224.

10.

Septic pulmonary embolism secondary to dental focus.

Serefhanoglu K, Bayindir Y, Ersoy Y, Isik K, Hacievliyagil SS, Serefhanoglu S.

Quintessence Int. 2008 Oct;39(9):753-6.

PMID:
19093048
11.

Prevalence of COPD: first epidemiological study of a large region in Turkey.

Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, Mutlu LC, Pehlivan E.

Eur J Intern Med. 2008 Nov;19(7):499-504. doi: 10.1016/j.ejim.2007.06.028. Epub 2008 Mar 14.

PMID:
19013377
12.

The relationship between severity of liver cirrhosis and pulmonary function tests.

Yigit IP, Hacievliyagil SS, Seckin Y, Oner RI, Karincaoglu M.

Dig Dis Sci. 2008 Jul;53(7):1951-6. Epub 2007 Dec 13.

PMID:
18080769
13.

[Value of plasma BNP levels as a prognostic marker in lung and heart disorders].

Yetkin O, Aksoy Y, Turhan H, In E, Karahan M, Kiliç T, Hacievliyagil SS, Günen H.

Tuberk Toraks. 2007;55(3):225-30. Turkish.

PMID:
17978918
14.

Assessment of B-type natriuretic peptide in patients with pneumonia.

Yetkin O, Hacievliyagil SS, Gunen H.

Int J Clin Pract. 2008 Mar;62(3):488-91. Epub 2007 Oct 3.

PMID:
17916178
15.

The role of nebulised budesonide in the treatment of exacerbations of COPD.

Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, Mutlu LC, In E.

Eur Respir J. 2007 Apr;29(4):660-7. Epub 2007 Jan 24. Erratum in: Eur Respir J. 2014 Jul;44(1):272.

16.

The role of arterial blood gases, exercise testing, and cardiac examination in asthma.

Gunen H, Hacievliyagil SS, Kosar F, Gulbas G, Kizkin O, Sahin I.

Allergy Asthma Proc. 2006 Jan-Feb;27(1):45-52.

PMID:
16598992
17.

Clinical significance of pulmonary function tests in patients with acute pancreatitis.

Ates F, Hacievliyagil SS, Karincaoglu M.

Dig Dis Sci. 2006 Jan;51(1):7-10.

PMID:
16416201
18.

Prevalence and clinical significance of a patent foramen ovale in patients with chronic obstructive pulmonary disease.

Hacievliyagil SS, Gunen H, Kosar FM, Sahin I, Kilic T.

Respir Med. 2006 May;100(5):903-10. Epub 2005 Oct 7.

19.

Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.

Hacievliyagil SS, Gunen H, Mutlu LC, Karabulut AB, Temel I.

Respir Med. 2006 May;100(5):846-54. Epub 2005 Oct 7.

20.

Factors affecting survival of hospitalised patients with COPD.

Gunen H, Hacievliyagil SS, Kosar F, Mutlu LC, Gulbas G, Pehlivan E, Sahin I, Kizkin O.

Eur Respir J. 2005 Aug;26(2):234-41.

21.

[The cost of treatment in new case and multidrug resistant case in pulmonary tuberculosis].

Kizkin O, Hacievliyagil SS, Türker G, Günen H.

Tuberk Toraks. 2003;51(4):410-5. Turkish.

PMID:
15143390
22.

[Acute oxygen treatment].

Kizkin O, Hacievliyagil SS, Günen H.

Tuberk Toraks. 2004;52(1):86-94. Review. Turkish.

PMID:
15143379
23.

Asthma, age, and early reversibility testing.

Kizkin O, Turker G, Hacievliyagil SS, Gunen H.

J Asthma. 2003 May;40(3):317-21.

PMID:
12807176

Supplemental Content

Loading ...
Support Center